Nasdaq Stocks

VUG, BA, NFLX, CRM: ETF Inflow Alert

5 years 6 months ago
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Growth ETF (Symbol: VUG) where we have detected an approximate $1.2 billion dollar inflow -- that's a 2.3% increase week over week in outs
BNK Invest

Wabtec (WAB) Q4 Earnings & Revenues Top Estimates, Rise Y/Y

5 years 6 months ago
Westinghouse Air Brake Technologies Corporation, which operates as Wabtec Corporation WAB, reported fourth-quarter 2019 earnings (excluding 33 cents from non-recurring items) of $1.04 per share, beating the Zacks Consensus Estimate by a penny. Moreover, the bottom line improved
Zacks

Service Corporation (SCI) Q4 Earnings In Line, Increase Y/Y

5 years 6 months ago
Service Corporation International SCI posted fourth-quarter 2019 results, wherein earnings were in line, while sales surpassed the Zacks Consensus Estimate. Further, both metrics improved year over year. Results were driven by solid performance in the funeral segment, partly off
Zacks

Wabtec (WAB) Beats Q4 Earnings Estimates

5 years 6 months ago
Westinghouse Air Brake Technologies Corporation, which operates as Wabtec Corporation WAB reported fourth-quarter 2019 2019 earnings (excluding 33 cents from non-recurring items) of $1.04 per share, beating the Zacks Consensus Estimate by a penny. Moreover, the bottom line impro
Zacks

Insight Enterprises Enters Oversold Territory

5 years 6 months ago
Insight Enterprises, Inc. NSIT has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at NSIT given that, according to its RSI reading of 21.63, it is now
Zacks

Here's Why You Should Retain Haemonetics in Your Portfolio Now

5 years 6 months ago
Haemonetics Corporation HAE is progressing well with its growth strategies like the expansion of the product portfolio within its plasma and Hemostasis Management franchise. However, economic uncertainty and tough competition are likely to offset the positives to some extent.
Zacks

Israel Chemicals (ICL) Q4 Earnings In Line, Revenues Down Y/Y

5 years 6 months ago
Israel Chemicals Ltd. ICL logged earnings of 4 cents per share in fourth-quarter 2019, down from 6 cents in the year-ago quarter. Earnings per share were in line with the Zacks Consensus Estimate.Revenues were $1,106 million for the reported quarter, down around 22% year over ye
Zacks
Checked
1 hour 36 minutes ago
This feed is responsible for generating the rss feed related to the topic Stocks
Subscribe to Nasdaq Stocks feed